Get the tools used by (smart)2 investors.
SP500 1.0%DOW 0.9%FTSE 100 0.7%NIKKEI 0.7%OIL 0.3%GOLD -0.6%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Total Debt / EBITDA for Innoviva Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

INVA: Innoviva Inc

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company’s products include RELVAR/BREO ELLIPTA, a once-daily co...

17.98 USD
Price
– USD
Fair Value
–
Upside
14.32 - 21.28
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Innoviva Inc's Total Debt / EBITDA:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0x5.0x10.0x15.0x20.0x25.0x
Performance Summary
  • Innoviva's latest twelve months total debt / ebitda is 2.5x
  • Innoviva's total debt / ebitda for fiscal years ending December 2020 to 2024 averaged 2.1x.
  • Innoviva's operated at median total debt / ebitda of 2.5x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Innoviva's total debt / ebitda peaked in December 2023 at 3.2x.
  • Innoviva's total debt / ebitda hit its 5-year low in December 2021 of 1.1x.
  • Innoviva's total debt / ebitda decreased in 2020 (1.2x, -22.0%), 2021 (1.1x, -11.9%), and 2024 (2.5x, -20.6%) and increased in 2022 (2.7x, +160.2%) and 2023 (3.2x, +15.2%).

How does Innoviva's Total Debt / EBITDA benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Innoviva Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Innoviva Total Debt / EBITDA Benchmarks
NameTickerTotal Debt / EBITDA
4Front Ventures CorpOTCPK:FFNT.F-48.5x
Evolus IncNASDAQGM:EOLS-6.4x
Tarsus Pharmaceuticals IncNASDAQGS:TARS-0.6x
HealthcareSECTOR:HLTH.US-0.1x
Vyne Therapeutics IncNASDAQCM:VYNE0.0x
Corcept Therapeutics IncorporatedNASDAQCM:CORT0.0x
Harmony Biosciences HoldingsNASDAQGM:HRMY0.8x
Merck & Company IncNYSE:MRK1.3x
AstraZeneca PLC ADRNASDAQGS:AZN1.7x
Innoviva IncNASDAQGS:INVA2.5x
AbbVie IncNYSE:ABBV2.5x
Pfizer IncNYSE:PFE2.8x

Metric Usage: Total Debt / EBITDA

Hide this widget
total_debt_to_ebitda
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Total Debt / EBITDA in the risk category include:

  • FCF / Net Income - This data item measures the ratio of levered free cash flow to net income to common, excluding extra items. It is a quick and helpful check on the quality of earnings.
  • Beneish M-Score - A statistical score that uses financial ratios to identify whether a company has manipulated its earnings
  • Net Debt / Total Capital - A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.
  • Cash Flow to Liabilities - A ratio that measures the amount of operating cash flow a firm generates on each dollar of total liabilities.
View Full List

Search for metric or datapoint

Total Debt / EBITDA

A ratio that is calculated as Total Debt (including Capital Leases) divided by EBITDA.

Definition of Total Debt / EBITDA

Hide this widget

Total Debt / EBITDA ratio measures leverage in terms of total debt while using EBITDA as a proxy for cash flow.

Short Term Borrowings
(+) Current Portion of Long Term Debt
(+) Current Portion of Lease Liabilities
(+) Long Term Debt
(+) Long Term Lease Liabilities
(=) Total Debt

EBITDA is Earnings before Interest, Taxes, Depreciation & Amortization
Click the link below to download a spreadsheet with an example Total Debt / EBITDA calculation for Innoviva Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-16.8x-7.8x1.2x16.8x0200400600800

The chart above depicts the distribution of total debt / ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,120 companies were considered in this analysis, and 2,042 had meaningful values. The average total debt / ebitda of companies in the sector is 0.6x with a standard deviation of 3.2x.

Innoviva Inc's Total Debt / EBITDA of 2.5x ranks in the 82.1% percentile for the sector. The following table provides additional summary stats:

Total Debt / EBITDA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,128
Included Constituents2,042
Min-16.4x
Max16.2x
Median0.0x
Mean0.6x
Standard Deviation3.2x

You can find companies with similar total debt / ebitda using this stock screener.

All rights reserved. Terms Of Use